Serum urate, the end product of purine metabolism, and an unusually clean example of a test that is definitive for one condition and speculative for everything else. It directly causes gout through crystal deposition in joints. Its observational associations with hypertension, metabolic syndrome and cardiovascular disease are a different proposition entirely.
Mendelian randomisation studies have largely failed to confirm a causal role for uric acid in cardiovascular outcomes, suggesting the observational association reflects confounding by obesity, alcohol, kidney function and diet rather than a direct causal pathway. Clearly useful for diagnosing and monitoring gout; not validated as a standalone cardiovascular or longevity risk marker, and no guideline recommends treating asymptomatic hyperuricaemia to reduce cardiovascular risk.
Singapore guidance
Not covered in the current review
Singapore’s national screening committee has not reviewed this test in the current volume of its report, which covers nine conditions. That is not a verdict either way.
Source: Screening Test Review Committee report 2026, Volume 1 (Academy of Medicine Singapore and Ministry of Health, February 2026). The full national list · How this is used.
What you would actually pay
- Healthier SG
- Not subsidised
- MediSave
- Not among the screenings named for outpatient claims
Source: Healthier SG Screening (HealthHub) and MediSave outpatient care (Ministry of Health). Absence from either list is not a statement that the test is discouraged — only that no subsidy or claim applies. Gross prices compared.
What it costs when it is wrong
- Basis
- No published harm criterion found
- Severity
- Not documented
Not covered in the current volume of the committee’s report, so no harm criterion was found either way.
An empty finding, not a clean bill of health: this means nothing documented was found for this test. It is not a claim that the test is safe.
Screening harm is not only a laboratory question: the committee’s own criteria advise against a test when “the screening test, or follow-up tests arising from a positive screen, are associated with significant medical risks”. Sources on overdiagnosis → · How this is graded.
FAQ
Is the Uric Acid worth doing in Singapore?
Uric Acid holds a weak evidence grade under our screening rubric. It typically costs S$15–25 in Singapore. It is ordered on symptoms (joint pain suggestive of gout) or as part of metabolic workup — not routine. It is most appropriate for suspected gout, kidney stone history, or monitoring urate-lowering therapy.
Weighing this against something else? Compare it with two other tests → · Price it inside a panel →